Jupiter Asset Management Ltd. Cuts Stock Holdings in Corteva, Inc. $CTVA

Jupiter Asset Management Ltd. trimmed its stake in shares of Corteva, Inc. (NYSE:CTVA) by 57.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 415,289 shares of the company’s stock after selling 561,157 shares during the period. Jupiter Asset Management Ltd. owned 0.06% of Corteva worth $27,837,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CTVA. Activest Wealth Management grew its stake in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC purchased a new position in Corteva during the third quarter valued at $25,000. Redmont Wealth Advisors LLC purchased a new position in Corteva during the third quarter valued at $29,000. Jackson Grant Investment Advisers Inc. grew its stake in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after acquiring an additional 213 shares in the last quarter. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in Corteva during the third quarter valued at $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

Shares of NYSE:CTVA opened at $78.41 on Friday. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The stock has a market capitalization of $52.44 billion, a P/E ratio of 46.12, a PEG ratio of 2.47 and a beta of 0.59. The firm has a fifty day simple moving average of $81.33 and a two-hundred day simple moving average of $74.53. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period last year, the company posted $1.13 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several research analyst reports. Morgan Stanley raised their target price on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday. CICC Research raised their target price on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Argus raised their target price on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. Finally, Rothschild & Co Redburn lifted their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.